Structural modification of resveratrol analogue exhibits anticancer activity against lung cancer stem cells via suppression of Akt signaling pathway

Abstract Background Compound with cancer stem cell (CSC)-suppressing activity is promising for the improvement of lung cancer clinical outcomes. Toward this goal, we discovered the CSC-targeting activity of resveratrol (RES) analog moscatilin (MOS). With slight structural modification from RES, MOS...

Full description

Bibliographic Details

Published in:	BMC Complementary Medicine and Therapies
Main Authors:	Sunisa Thongsom, Satapat Racha, Korrakod Petsri, Zin Zin Ei, Kittichate Visuttijai, Sohsuke Moriue, Masashi Yokoya, Pithi Chanvorachote
Format:	Article
Language:	English
Published:	BMC 2023-06-01
Subjects:	Moscatilin Resveratrol Lung cancer Akt pathway CSCs Molecular docking
Online Access:	https://doi.org/10.1186/s12906-023-04016-6